Journal of Natural Products · 1999 · 73 citations · 10 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryMedicinal PlantsNatural Product Drug DiscoveryStructure-activity Relationship AnalysisActive Compound IsolationAlkaloid ExtractionBioassay DevelopmentBiological Evaluation ReportPharmacological ScreeningPlant AlkaloidsPotency MeasurementTotal Synthesis-derived Analogues
Bioassay-guided fractionation of an extract of a mixture of Microphilis guyanensis and Genipa americanacollected in the rainforest of Suriname yielded the known alkaloid cryptolepine (2) as the major active compound in a yeast bioassay for potential DNA-damaging agents; the same compound was later reisolated from M. guyanensis. The structure of cryptolepine was identified unambiguously by spectral data and by its total synthesis. Several cryptolepine derivatives (3-29, 32-41) were synthesized based on modifications of the C-2, N-5, N-10, and C-11 positions. Two cryptolepine dimers (30, 31) were also prepared. The structure modifications did not result in compounds with a higher potency than the parent compound cryptolepine in the yeast assay system, although some derivatives did show significant activity. Selected compounds (6, 7, 17, 22, 23, 26, and 27) were also tested for cytotoxicity in mammalian cell culture, and two compounds showed significant cytotoxic activity.
10
New alkaloids from Cryptolepis sanguinolenta
K. Cimanga, Tess De Bruyne, Luc Pieters et al. · Tetrahedron Letters · 1996 · 189 citations
J. Jeffry Howbert, C. S. Grossman, Thomas A. Crowell et al. · Journal of Medicinal Chemistry · 1990 · 136 citations
Isocryptolepine from Cryptolepis sanguinolenta
Jean‐Louis Pousset, Marie‐Thérèse Martin, Akino Jössang et al. · Phytochemistry · 1995 · 123 citations